Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
6.43B | 6.78B | 6.29B | 5.93B | 4.00B |
Gross Profit | ||||
2.46B | 1.80B | 1.54B | 1.58B | 1.09B |
EBIT | ||||
-562.00M | -637.00M | -822.00M | -1.09B | -651.00M |
EBITDA | ||||
7.78B | 5.30B | 9.90B | 659.00M | 97.00M |
Net Income Common Stockholders | ||||
2.85B | 4.33B | 12.22B | 5.30B | 3.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
19.26B | 21.28B | 13.66B | 6.46B | 8.36B |
Total Assets | ||||
62.27B | 65.50B | 71.32B | 53.82B | 36.32B |
Total Debt | ||||
16.50B | 16.34B | 16.19B | 8.20B | 3.82B |
Net Debt | ||||
14.68B | 14.93B | 14.74B | 6.90B | 2.90B |
Total Liabilities | ||||
20.99B | 20.89B | 21.19B | 12.96B | 6.39B |
Stockholders Equity | ||||
17.87B | 18.96B | 20.58B | 29.19B | 21.75B |
Cash Flow | Free Cash Flow | |||
936.00M | -479.00M | -981.00M | -68.00M | -310.00M |
Operating Cash Flow | ||||
1.03B | -177.00M | -702.00M | 73.00M | -196.00M |
Investing Cash Flow | ||||
142.00M | 12.62B | 6.05B | -678.00M | 2.44B |
Financing Cash Flow | ||||
-8.24B | -12.16B | 754.00M | 53.00M | -121.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $21.51B | 20.43 | 10.75% | 1.09% | 0.63% | 34.09% | |
76 Outperform | $28.61B | 9.02 | 9.14% | ― | -2.60% | 16.71% | |
76 Outperform | $17.85B | 9.75 | 47.49% | ― | 19.35% | ― | |
68 Neutral | $75.00B | 681.09 | 1.68% | ― | 24.17% | ― | |
64 Neutral | $18.30B | ― | -27.12% | ― | 61.71% | -442.46% | |
63 Neutral | $36.49B | 12.09 | 17.75% | 0.21% | 11.37% | ― | |
58 Neutral | $26.33B | 3.17 | -10.68% | 4.33% | 2.16% | -43.07% |